← All Mutual Funds

abrdn Healthcare Investors

CIK: 0000805267 HQH Equity
Report date: 2026-02-27
AUM $1.2B
Expense Ratio
Category Equity
State MA
Fiscal Year End
Inception Date
Manager
Latest Filing 2026-02-27

About this Fund

abrdn Healthcare Investors is a leading mutual fund company that specializes in providing expert asset management solutions to investors seeking to capitalize on the growth potential of the healthcare sector. With a strong focus on investment excellence and a commitment to delivering exceptional returns, abrdn Healthcare Investors offers a diverse range of mutual funds that cater to the unique needs and risk profiles of its investors. The company's portfolio of funds includes equity, debt, and hybrid options, allowing investors to choose from a variety of investment strategies that align with their financial goals and objectives. For those seeking a disciplined and consistent approach to investing, abrdn Healthcare Investors also offers systematic investment plans (SIPs) that enable investors to invest a fixed amount of money at regular intervals, thereby reducing the impact of market volatility and timing risks. As a trusted name in the wealth management industry, abrdn Healthcare Investors is dedicated to helping its investors achieve their long-term financial objectives through a combination of rigorous research, careful portfolio construction, and ongoing monitoring and evaluation. The company's investment team comprises experienced professionals with a deep understanding of the healthcare sector, including its trends, challenges, and opportunities. By leveraging their expertise and insights, abrdn Healthcare Investors is able to identify attractive investment opportunities and create portfolios that are well-positioned to deliver strong returns over the long term. Whether investors are seeking to grow their wealth, generate income, or preserve their capital, abrdn Healthcare Investors offers a range of mutual fund options that can help them achieve their goals. With its strong investment capabilities, customer-centric approach, and commitment to transparency and accountability, abrdn Healthcare Investors has established itself as a trusted partner for investors seeking to navigate the complexities of the healthcare sector and achieve their financial aspirations. The company's investor-focused approach is built around a deep understanding of the needs and concerns of its clients, including individual investors, financial advisors, and institutional investors. By providing timely and relevant information, responsive customer service, and ongoing support and guidance, abrdn Healthcare Investors helps its investors make informed decisions and stay on track with their investment plans. As a result, the company has earned a reputation for excellence and trust among its investors, who appreciate its commitment to delivering exceptional investment results and outstanding client service. With its expertise in asset management, investment research, and portfolio management, abrdn Healthcare Investors is well-positioned to help its investors succeed in an increasingly complex and dynamic investment landscape. By choosing abrdn Healthcare Investors, investors can tap into the company's extensive knowledge and experience, gain access to a range of high-quality mutual funds, and benefit from a wealth management approach that is tailored to their unique needs and objectives.

Holdings

From latest SEC N-PORT filing · US-listed stocks only

68 positions
# Security Name CUSIP Asset Type Weight % Value ($M) Quantity
1 ABT Abbott Laboratories Since 2026-05-10 002824100 Equity (Common)
1.81%
$21.12 168,607
2 ABBV AbbVie Inc Since 2026-05-10 00287Y109 Equity (Common)
0.75%
$8.71 38,114
3 JBIO Jade Biosciences Inc Since 2026-05-10 008064206 Equity (Common)
0.78%
$9.10 589,729
4 ALNY Alnylam Pharmaceuticals Inc Since 2026-05-10 02043Q107 Equity (Common)
1.50%
$17.50 43,997
5 AMGN Amgen Inc Since 2026-05-10 031162100 Equity (Common)
3.41%
$39.79 121,573
6 AQST Aquestive Therapeutics Inc Since 2026-05-10 03843E104 Equity (Common)
0.31%
$3.57 553,298
7 ACLX Arcellx Inc Since 2026-05-10 03940C100 Equity (Common)
0.23%
$2.66 40,802
8 RCUS Arcus Biosciences Inc Since 2026-05-10 03969F109 Equity (Common)
0.28%
$3.23 135,668
9 ARQT Arcutis Biotherapeutics Inc Since 2026-05-10 03969K108 Equity (Common)
0.75%
$8.78 302,408
10 ARWR Arrowhead Pharmaceuticals Inc Since 2026-05-10 04280A100 Equity (Common)
0.94%
$11.01 165,758
11 AZN AstraZeneca PLC Since 2026-05-10 046353108 Equity (Common)
0.75%
$8.70 94,624
12 AXSM Axsome Therapeutics Inc Since 2026-05-10 05464T104 Equity (Common)
0.91%
$10.56 57,848
13 BCRX BioCryst Pharmaceuticals Inc Since 2026-05-10 09058V103 Equity (Common)
0.26%
$3.06 392,172
14 CRL Charles River Laboratories International Inc Since 2026-05-10 159864107 Equity (Common)
0.65%
$7.57 37,946
15 CDXS Codexis Inc Since 2026-05-10 192005106 Equity (Common)
0.73%
$8.53 5,232,466
16 CRBP Corbus Pharmaceuticals Holdings Inc Since 2026-05-10 21833P301 Equity (Common)
0.54%
$6.33 778,031
17 CRNX Crinetics Pharmaceuticals Inc Since 2026-05-10 22663K107 Equity (Common)
1.63%
$19.06 409,392
18 DNLI Denali Therapeutics Inc Since 2026-05-10 24823R105 Equity (Common)
1.86%
$21.65 1,311,234
19 DXCM Dexcom Inc Since 2026-05-10 252131107 Equity (Common)
0.63%
$7.36 110,846
20 IRON Disc Medicine Inc Since 2026-05-10 254604101 Equity (Common)
0.46%
$5.37 67,652
21 DYN Dyne Therapeutics Inc Since 2026-05-10 26818M108 Equity (Common)
0.75%
$8.78 448,685
22 EWTX Edgewise Therapeutics Inc Since 2026-05-10 28036F105 Equity (Common)
1.00%
$11.65 469,325
23 EVMN Evommune Inc Since 2026-05-10 30054Y107 Equity (Common)
0.51%
$6.01 350,795
24 EYPT EyePoint Inc Since 2026-05-10 30233G209 Equity (Common)
1.67%
$19.52 1,068,537
25 GILD Gilead Sciences Inc Since 2026-05-10 375558103 Equity (Common)
0.32%
$3.69 30,027
26 GRAL GRAIL Inc Since 2026-05-10 384747101 Equity (Common)
0.61%
$7.13 83,325
27 GH Guardant Health Inc Since 2026-05-10 40131M109 Equity (Common)
0.35%
$4.08 39,905
28 HUM Humana Inc Since 2026-05-10 444859102 Equity (Common)
1.55%
$18.09 70,622
29 IDYA Ideaya Biosciences Inc Since 2026-05-10 45166A102 Equity (Common)
1.02%
$11.94 345,344
30 IMVT Immunovant Inc Since 2026-05-10 45258J102 Equity (Common)
1.62%
$18.88 742,624
31 IMUX Immunic Inc Since 2026-05-10 4525EP101 Equity (Common)
0.22%
$2.53 4,738,771
32 INSP Inspire Medical Systems Inc Since 2026-05-10 457730109 Equity (Common)
1.49%
$17.42 188,834
33 ISRG Intuitive Surgical Inc Since 2026-05-10 46120E602 Equity (Common)
1.26%
$14.68 25,913
34 IQV IQVIA Holdings Inc Since 2026-05-10 46266C105 Equity (Common)
0.38%
$4.44 19,691
35 KRYS Krystal Biotech Inc Since 2026-05-10 501147102 Equity (Common)
0.53%
$6.22 25,239
36 LENZ LENZ Therapeutics Inc Since 2026-05-10 52635N103 Equity (Common)
0.46%
$5.34 333,822
37 MRK Merck & Co Inc Since 2026-05-10 58933Y105 Equity (Common)
1.45%
$16.92 160,742
38 MOH Molina Healthcare Inc Since 2026-05-10 60855R100 Equity (Common)
1.00%
$11.69 67,362
39 NEO NeoGenomics Inc Since 2026-05-10 64049M209 Equity (Common)
0.79%
$9.19 781,788
40 NBIX Neurocrine Biosciences Inc Since 2026-05-10 64125C109 Equity (Common)
0.23%
$2.71 19,103
41 NUVL Nuvalent Inc Since 2026-05-10 670703107 Equity (Common)
0.83%
$9.64 95,867
42 PSNL Personalis Inc Since 2026-05-10 71535D106 Equity (Common)
1.29%
$15.09 1,895,842
43 PRAX Praxis Precision Medicines Inc Since 2026-05-10 74006W207 Equity (Common)
1.29%
$15.09 51,206
44 REGN Regeneron Pharmaceuticals Inc Since 2026-05-10 75886F107 Equity (Common)
2.81%
$32.79 42,487
45 RVMD Revolution Medicines Inc Since 2026-05-10 76155X100 Equity (Common)
0.52%
$6.10 76,590
46 SRPT Sarepta Therapeutics Inc Since 2026-05-10 803607100 Equity (Common)
1.74%
$20.26 941,560
47 SERA Sera Prognostics Inc Since 2026-05-10 81749D107 Equity (Common)
0.29%
$3.38 1,145,722
48 SPRY ARS Pharmaceuticals Inc Since 2026-05-10 82835W108 Equity (Common)
1.41%
$16.49 1,415,750
49 SION Sionna Therapeutics Inc Since 2026-05-10 829401108 Equity (Common)
2.06%
$24.09 585,546
50 SLNO Soleno Therapeutics Inc Since 2026-05-10 834203309 Equity (Common)
0.75%
$8.80 190,001
51 SMMT Summit Therapeutics Inc Since 2026-05-10 86627T108 Equity (Common)
0.90%
$10.54 602,438
52 TNDM Tandem Diabetes Care Inc Since 2026-05-10 875372203 Equity (Common)
0.54%
$6.34 288,261
53 TECX Tectonic Therapeutic Inc Since 2026-05-10 878972108 Equity (Common)
1.38%
$16.08 770,940
54 TEM Tempus AI Inc Since 2026-05-10 88023B103 Equity (Common)
0.85%
$9.95 168,493
55 TMO Thermo Fisher Scientific Inc Since 2026-05-10 883556102 Equity (Common)
0.72%
$8.39 14,478
56 TVTX Travere Therapeutics Inc Since 2026-05-10 89422G107 Equity (Common)
1.02%
$11.94 312,492
57 TCRX TScan Therapeutics Inc Since 2026-05-10 89854M101 Equity (Common)
0.07%
$0.84 843,548
58 RARE Ultragenyx Pharmaceutical Inc Since 2026-05-10 90400D108 Equity (Common)
1.84%
$21.50 934,901
59 PCVX Vaxcyte Inc Since 2026-05-10 92243G108 Equity (Common)
2.51%
$29.29 634,734
60 VIR Vir Biotechnology Inc Since 2026-05-10 92764N102 Equity (Common)
0.45%
$5.30 879,214
61 IMUX IMMUNIC INC. Since 2026-05-10 Derivative 5,247,245
62 IMUX IMMUNIC INC. Since 2026-05-10 Derivative
0.24%
$2.80 5,247,245
63 IMUX IMMUNIC INC. Since 2026-05-10 Derivative
0.09%
$1.03 5,247,245
64 XENE Xenon Pharmaceuticals Inc Since 2026-05-10 98420N105 Equity (Common)
1.74%
$20.29 452,730
65 ZTS Zoetis Inc Since 2026-05-10 98978V103 Equity (Common)
1.09%
$12.72 101,117
66 JAZZ Jazz Pharmaceuticals PLC Since 2026-05-10 Equity (Common)
0.69%
$8.07 47,492
67 MDT Medtronic PLC Since 2026-05-10 Equity (Common)
0.88%
$10.26 106,833
68 OCS Oculis Holding AG Since 2026-05-10 Equity (Common)
0.99%
$11.57 579,536
Frequently Asked Questions — abrdn Healthcare Investors
What type of mutual fund is abrdn Healthcare Investors?
abrdn Healthcare Investors is a SEC-registered Equity fund, with $1.2B in assets under management. Equity funds invest primarily in a diversified portfolio of stocks and equities, aiming for long-term capital appreciation. They carry higher market risk than bond or money market funds but historically offer stronger long-term returns. Equity mutual funds can be further classified as large-cap, mid-cap, small-cap, growth, value, or sector-specific depending on their investment mandate. As of its latest SEC N-PORT filing, abrdn Healthcare Investors holds 68 portfolio positions, all detailed in the holdings table on this page.
What are abrdn Healthcare Investors's assets under management (AUM)?
abrdn Healthcare Investors has $1.2B in assets under management (AUM) according to its most recent SEC N-PORT filing on StockSifting. AUM represents the total market value of all securities and other assets held by the fund as of the report date. A larger AUM generally signals a more established fund with greater institutional adoption, more trading liquidity, and potentially lower per-unit operational costs due to economies of scale. AUM changes daily as market prices fluctuate and as investors purchase or redeem fund shares — the figure shown here reflects the most recently available N-PORT disclosure, not the current real-time value. For the live figure, consult the fund's official website or its latest SEC EDGAR filing.
What are abrdn Healthcare Investors's top holdings?
According to abrdn Healthcare Investors's most recent SEC N-PORT filing, the fund's largest holdings by portfolio weight include Abbott Laboratories, AbbVie Inc, Jade Biosciences Inc , among others. The complete list of all 68 holdings — including CUSIP, asset type, portfolio weight percentage, dollar value, and share quantity — is available in the holdings table above. Holdings data is sourced directly from SEC EDGAR N-PORT filings and reflects the fund's positions as of the report date shown at the top of this page. Due to the 60-day SEC disclosure lag, these positions may differ from the fund's current portfolio. For the latest holdings before public release, refer to SEC EDGAR directly.
What is abrdn Healthcare Investors's expense ratio?
Expense ratio data for abrdn Healthcare Investors is not currently available in StockSifting's database. The expense ratio is the annual fee charged by a mutual fund as a percentage of your investment, covering management fees and operational costs. It is one of the most important factors affecting net long-term returns — lower expense ratios allow more of a fund's gross performance to flow through to investors. For the most accurate and current expense ratio, refer to the fund's official prospectus or its SEC EDGAR filings. You can also contact us if you believe this data should be present.
Where can I find abrdn Healthcare Investors's SEC filings?
abrdn Healthcare Investors is required to file monthly portfolio reports (Form N-PORT) with the U.S. Securities and Exchange Commission (SEC). Its SEC Central Index Key (CIK) is 0000805267. You can access all of abrdn Healthcare Investors's SEC filings — including N-PORT holdings disclosures, annual reports (Form N-CEN), and registration statements — directly on SEC EDGAR (CIK: 0000805267). N-PORT filings disclose the fund's complete portfolio holdings, fair value measurements, and certain risk metrics as of each filing period end date. StockSifting automatically parses these filings to populate the holdings table, AUM figures, and expense ratio displayed on this page, making the raw EDGAR data accessible without needing to download and parse XML files manually.
How current is abrdn Healthcare Investors's holdings data on StockSifting?
Holdings data for abrdn Healthcare Investors on StockSifting is sourced from its most recent SEC EDGAR N-PORT filing. Under SEC rules, registered investment companies must file N-PORT reports monthly, but these are made publicly available approximately 60 days after the reporting period end date. This means the holdings shown on this page reflect the fund's portfolio from roughly two months prior — not today's exact positions. The Report date displayed at the top of this page indicates exactly when the underlying data was current. If the fund has made significant portfolio changes since that date — responding to market events, earnings releases, or macro shifts — those changes will not be reflected here until the next N-PORT filing is released. For the most up-to-date holdings before the public disclosure window, refer to the fund's official website or SEC EDGAR directly. StockSifting is best used for fundamental research and historical portfolio analysis, not real-time trading decisions.